Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Revenue | 6,436,803 | 6,040,619 | 4,653,415 | 3,329,494 |
Cost of Revenue | 5,315,016 | 4,997,746 | 3,819,232 | 2,782,168 |
Gross Profit | 1,121,787 | 1,042,873 | 834,183 | 547,326 |
Operating Expenses | ||||
Research Development | -- | -- | -- | -- |
Selling General and Administrative | 256,149 | -- | 580,686 | 454,996 |
Non Recurring | -- | -- | -- | -- |
Others | 650,774 | 814,286 | 31,923 | 6,667 |
Total Operating Expenses | 906,923 | 814,286 | 612,609 | 461,663 |
Operating Income or Loss | 214,864 | 228,587 | 221,574 | 85,663 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (6,717) | 11,996 | 63,592 | (25,556) |
Earnings Before Interest And Taxes | 231,551 | 220,735 | 278,092 | 54,770 |
Interest Expense | -- | -- | 56,872 | 55,975 |
Income Before Tax | 84,365 | 122,388 | 221,220 | (1,205) |
Income Tax Expense | 30,584 | 32,824 | 54,021 | 5,418 |
Minority Interest | 29,982 | 28,898 | 25,998 | 20,946 |
Net Income From Continuing Ops | 53,781 | 89,564 | 167,199 | (6,623) |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | (3,291) | (5,624) | (2,992) | (832) |
Net Income | 50,490 | 83,940 | 164,207 | (7,455) |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | 50,490 | 83,940 | 164,207 | (7,455) |